Home page | Help | Clear

English | French

Search | Categories | Titles A-Z | Countries | Compare countries | Index

Expand Document

Printable HTML version

Export document as HTML file Help


	National Drug Policy (Second Edition) - Ghana (GNDP; 2004; 37 pages)
		PREFACE
		ACKNOWLEDGEMENT
		LIST OF ACRONYMS
		INTRODUCTION
		GOAL
		OBJECTIVES
		SITUATIONAL ANALYSIS
		1.0 DRUG SELECTION
			1.1 Preamble
			1.2 Objective
			1.3 Policy Statement
				1.3.1 Essential Drugs
		2.0 DRUG PROCUREMENT, STORAGE AND DISTRIBUTION
			2.1 Preamble
			2.2 Objective
			2.3 Policy Statement
				2.3.1. Procurement
				2.3.2 Storage
				2.3.3 Distribution
		3.0 DRUG FINANCING
			3.1 Preamble
			3.2 Objective
			3.3 Policy Statement
		4.0 QUALITY ASSURANCE
			4.1 Preamble
			4.2 Objective
			4.3 Policy statement
				4.3.1 Quality of Drugs.
				4.3.2 Drug Registration
				4.3.3 Quality of service
				4.3.4 Drug Advertisement and Promotion
		5.0 LOCAL MANUFACTURE OF PHARMACEUTICAL AND TRADITIONAL MEDICINAL PRODUCTS
			5.1 Preamble
			5.2 Objective
			5.3 Policy statement
		6.0 RATIONAL DRUG USE
			6.1 Preamble
			6.2 Objective
			6.3 Policy Statement
				6.3.1 Education and Training
				6.3.2 Drug Information
				6.3.3 Prescribing
				6.3.4 Dispensing
				6.3.5 Patient Compliance and Self-Medication
				6.3.6 Drug and Therapeutics Committees
				6.3.7 Disposal of expired drugs.
				6.3.8 Pharmacovigilance
		7.0 GLOBAL TRADE AND PHARMACEUTICALS
			7.1 Preamble
			7.2 Objective
			7.3 Policy statement
		8.0 EMERGING DISEASES AND PHARMACEUTICALS
			8.1 Preamble
			8.2 Objective
			8.3 Policy statement
		9.0 HUMAN RESOURCE DEVELOPMENT FOR DRUG MANAGEMENT
			9.1 Preamble
			9.2 Objectives
			9.3 Policy statement
		10.0 TRADITIONAL MEDICINAL PRODUCTS
			10.1 Preamble
			10.2 Objective
			10.3 Policy Statement
		11.0 RESEARCH AND DEVELOPMENT
			11.1 Preamble
			11.2 Objective
			11.3 Policy statement
		12.0 NATIONAL DRUG POLICY IMPLEMENTATION
			12.1 Preamble
			12.2 Objective
			12.3 Policy statement
				12.3.1 Operationalisation of Policy
				12.3.2 Monitoring and evaluation
		ANNEX A: DEFINITIONS
		ANNEX B: RELEVANT REGULATIONS ON PHARMACEUTICALS

National Drug Policy (Second Edition) - Ghana

REPUBLIC OF GHANA

July 2004

© 2004 Ministry of Health (GNDP) Ghana

1^st Edition	1999
2^nd Edition	2004

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording and/or otherwise, without prior written permission of Ministry of Health, Ghana.

ISBN 9988-0-0834-1

For all enquiries write to the publishers:

The Programme Manager
Ghana National Drugs Programme (GNDP)
Ministry of Health
P. O. Box MB-582, Accra, Ghana, West Africa
Tel: + 233 (0) 21 661 670/71
Fax: + 233 (0) 21 664 309
E-mail: gndp@ighmail.com

Printed by Yamens P. P. Limited, Accra, Ghana, West Africa.
Tel: + 233 (0) 21 223 222
E-mail: yamensgh@yahoo.co.ul

Materials Development Consultant: E.T.A. Abbey.
Address: P. O. Box AN 5116 Accra, Ghana, West Africa
Tel: + 233 (0) 21 304 211/+ 233 (0) 21 313 843

Designed by Robert A. Dussey
Telephone: + 233(0)21776329/ + 233
E-mail:alinco@yahoo.com

Please provide your feedback

English | French